President Donald Trump on Saturday signed an executive order aimed at encouraging expanded research into psychedelic drugs, part of a broader push to explore emerging mental health treatments.
“In many cases, these experimental treatments have shown life-changing potential for those suffering from severe mental illness and depression, including our cherished veterans,” Trump said during a signing event in the Oval Office.
The president also announced that the federal government is making a $50 million investment for further research into the psychedelic drug ibogaine.
Trump, ahead of signing the order, pointed to initial research he said demonstrates the drug’s potential and quipped that he wanted some himself.
“Can I have some, please? I’ll take some,” Trump said, adding that he would “take whatever it takes,” prompting laughter in the Oval. “I don’t have time to be depressed. You know, if you stay busy enough, maybe that works, too. That’s what I do.”
Continue reading the complete article on the original source
